Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 3/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.39 |
| ▸ | GRIA3 | P42263 | 2/20 | 0.39 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.39 |
| ▸ | GRM8 | O00222 | 1/20 | 0.39 |
| ▸ | GRM6 | O15303 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL29755 | 1.00 | BLM (0.53) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL9389369 | 0.96 | ALOX15 (0.49) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL2730156 | 0.96 | ALOX15 (0.49) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL2727906 | 0.96 | ALOX15 (0.49) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL6534153 | 0.95 | BLM (0.47) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL28193511 | 0.95 | BLM (0.47) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL20680473 | 0.95 | BLM (0.47) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL27730526 | 0.95 | BLM (0.47) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL17628714 | 0.95 | BLM (0.47) | BLMPMP22KMT2AALOX15SLC7A5 | |
| Histidine SCHEMBL27615311 | 0.94 | BLM (0.46) | BLMPMP22KMT2AALOX15SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0594540-B1 | Antiretroviral acyl compounds | CIBA GEIGY AG (CH) | 1998-04-01 | — | — | EP | claimed |
| WO-1992012952-A1 | MALIC ACID DERIVATIVES AND COMPOSITIONS FOR THE TREATMENT OF PSORIASIS | DEXTER CHEMICAL CORPORATION (US) | 1992-08-06 | — | — | WO | claimed |
| US-20230257427-A1 | INSECTICIDAL PEPTIDE PRODUCTION, PEPTIDE EXPRESSION IN PLANTS AND COMBINATIONS OF CYSTEINE RICH PEPTIDES | Vestaron Corporation (US) | 2023-08-17 | — | — | US | disclosed |
| US-11692016-B2 | High gene expression yeast strain | SUTERRA LLC | 2023-07-04 | — | — | US | disclosed |
| CN-108136208-B | Cannabinoid glycoside prodrugs and methods of synthesis | 统帅青凤蝶生物科学公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-107050462-B | Solution-particle phase transition type anti-tumor drug delivery system and preparation method thereof | 中山大学 | 2021-03-30 | — | — | CN | disclosed |
| EP-3766978-A1 | TOXIC PEPTIDE PRODUCTION, PEPTIDE EXPRESSION IN PLANTS AND COMBINATIONS OF CYSTEINE RICH PEPTIDES | Vestaron Corporation (US) | 2021-01-20 | — | — | EP | disclosed |
| US-20200277345-A1 | Insecticidal Peptide Production, Peptide Expression in Plants and Combinations of Cysteine Rich Peptides | Vestaron Corporation (US) | 2020-09-03 | — | — | US | disclosed |
| US-20200255482-A1 | INSECTICIDAL COMBINATIONS | Vestaron Corporation (US) | 2020-08-13 | — | — | US | disclosed |
| US-20200207818-A1 | HIGH GENE EXPRESSION YEAST STRAIN | Vestaron Corporation (US) | 2020-07-02 | — | — | US | disclosed |
| US-10669319-B2 | Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides | Vestaron Corporation (US) | 2020-06-02 | — | — | US | disclosed |
| CN-1217927-C | Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism | AVENTIS PHARMA GMBH (DE) | 2005-09-07 | — | — | CN | disclosed |
| CN-1662493-A | Ring-substituted diphenyl 2-azetidinones, method for the production thereof, medicaments containing said compounds and the use thereof | AVENTIS PHARMA GMBH (DE) | 2005-08-31 | — | — | CN | disclosed |
| CN-1618801-A | D-aminoacylase mutants | DAICEL CHEM (JP) | 2005-05-25 | — | — | CN | disclosed |
| CN-1173951-C | Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use | ���ĵ�˹ҩ��¹�����˾ | 2004-11-03 | — | — | CN | disclosed |
| US-6753177-B1 | USED IN DRUG SCREENING FOR INHIBITORS OF DOG P-GLYCOPROTEIN (PGP) | BECTON DICKINSON AND COMPANY | 2004-06-22 | — | — | US | disclosed |
| CN-1498223-A | Anti-angiogenic polypeptides | M | 2004-05-19 | — | — | CN | disclosed |
| CN-1483021-A | Novel 1, 2-diphenyl azetidinones, process for their preparation, medicaments containing them and their use in the treatment of disorders of lipid metabolism | ���ĵ�˹ҩ��¹�����˾ | 2004-03-17 | — | — | CN | disclosed |
| EP-1220911-A2 | P-GLYCOPROTEINS AND USES THEREOF | GENTEST CORPORATION (US) | 2002-07-10 | — | — | EP | disclosed |
| WO-2001023540-A2 | P-GLYCOPROTEINS AND USES THEREOF | GENTEST CORPORATION (US) | 2001-04-05 | — | — | WO | disclosed |